The brief opens with the tension Aveeno has earned the right to solve. Seventy-eight percent of sensitive-skin shoppers say they "miss smelling like something" — and the category trained them to stop trying. The new Daily Moisturizing Sensitive Skin Scents collection is the unlock. The campaign just needs to give them permission to want it again.
Aveeno's scented Daily Moisturizing line is selling 32% below first-90-day plan.
Distribution is at 92% — shelves are full. Awareness ran in Q2 and pulled trial in line with forecast (1.4M units). The variant isn't the problem — consumers love the smell. The problem is repeat. Forty-one percent return for a second purchase, against 58% on the unscented line. They tried it, they loved it, and then they got nervous. They don't know it's safe to keep using it. Q3 has to teach them, fast, before the holiday gifting window closes.
"The pragmatic sensitive" — women 28–45 who've been let down by lotion before.
42 million US women, primary household skincare buyer, three or more skin reactions in the past year. They self-screen at the shelf — they read the back of the bottle, scan for "fragrance" in the ingredients, and put it back. They buy Cetaphil. They buy CeraVe. They buy Aveeno unscented. They want to like body care more than they currently do. They miss perfume. They miss feeling like a person who smells nice.
I haven't worn lotion that smelled like anything since I was twenty-two. I forgot smelling nice was even a thing for me.
Sensitive-skin shoppers don't avoid fragrance because they hate it. They've learned to grieve it.
The category trained a generation of women to think "scented" means "irritation." Their relationship with fragrance is a sequence of small losses — perfume that broke them out, hand cream that flared their hands, body wash they had to throw away. They don't need a louder fragrance pitch. They need permission to try again. That single shift — from sell to permission — is the strategic platform of the entire campaign.
"You can have soft skin and smell like cocoa butter. We tested it for three years so you don't have to."
The single message creative needs to carry. Says it's safe (three years of testing), names what it smells like (cocoa butter, vanilla, apricot), and frames it as the consumer reclaiming an experience — not the brand launching a thing. Not "Aveeno launches scented." Not "We've never been more aromatic." The line is "you don't have to choose anymore." Every piece of the work should ladder back to it.
Sensory but never theatrical. Warm-derm, not luxury. Cocoa butter — never patchouli.
Aveeno is a derm-trusted everyday brand. The work should feel like permission, not a fragrance ad. Real women, real skin, soft light, kitchen-table feel. Sound design carries weight here — the "uncap, deep breath, smile" beat is the campaign's audio thumbprint and should appear in every cut from 6s to 60s. We're not making perfume. We're not selling lotion. We're returning a small daily pleasure to people who'd given up on it.
"Permission to want fragrance again."
"Ceramides, barrier, clinical."
"French derm rigor. Eczema-grade."
"Smells incredible. (Skip if sensitive.)"
One sign-off triggers the rest of Section V — Pre-Mortem on the concepts (May 19), Test Plan for creative variants (Jun 10), Performance Read at mid-flight (Aug 11), and the Launch Playbook on Sep 22. The brief is the upstream input for all of them.